Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Behavioural Effects of Using Sulfasalazine to Inhibit Glutamate Released by Cancer Cells: A Novel target for Cancer-Induced Depression.

Nashed MG, Ungard RG, Young K, Zacal NJ, Seidlitz EP, Fazzari J, Frey BN, Singh G.

Sci Rep. 2017 Jan 25;7:41382. doi: 10.1038/srep41382.

2.

Differences in electrophysiological properties of functionally identified nociceptive sensory neurons in an animal model of cancer-induced bone pain.

Zhu YF, Ungard R, Seidlitz E, Zacal N, Huizinga J, Henry JL, Singh G.

Mol Pain. 2016 Mar 1;12. pii: 1744806916628778. doi: 10.1177/1744806916628778. Print 2016.

3.

Depressive-like behaviours and decreased dendritic branching in the medial prefrontal cortex of mice with tumors: A novel validated model of cancer-induced depression.

Nashed MG, Seidlitz EP, Frey BN, Singh G.

Behav Brain Res. 2015 Nov 1;294:25-35. doi: 10.1016/j.bbr.2015.07.040. Epub 2015 Jul 26.

PMID:
26222786
4.

Inhibition of breast cancer-cell glutamate release with sulfasalazine limits cancer-induced bone pain.

Ungard RG, Seidlitz EP, Singh G.

Pain. 2014 Jan;155(1):28-36. doi: 10.1016/j.pain.2013.08.030. Epub 2013 Aug 30.

PMID:
23999057
5.

Oxidative stress and cancer pain.

Ungard RG, Seidlitz EP, Singh G.

Can J Physiol Pharmacol. 2013 Jan;91(1):31-7. doi: 10.1139/cjpp-2012-0298. Epub 2013 Jan 1. Review.

PMID:
23368277
6.

Glutamate signaling in healthy and diseased bone.

Cowan RW, Seidlitz EP, Singh G.

Front Endocrinol (Lausanne). 2012 Jul 19;3:89. doi: 10.3389/fendo.2012.00089. eCollection 2012.

7.

Extracellular glutamate alters mature osteoclast and osteoblast functions.

Seidlitz EP, Sharma MK, Singh G.

Can J Physiol Pharmacol. 2010 Sep;88(9):929-36. doi: 10.1139/y10-070.

PMID:
20921979
8.

Evidence for the role of matrix metalloproteinase-13 in bone resorption by giant cell tumor of bone.

Mak IW, Seidlitz EP, Cowan RW, Turcotte RE, Popovic S, Wu WC, Singh G, Ghert M.

Hum Pathol. 2010 Sep;41(9):1320-9. doi: 10.1016/j.humpath.2010.03.001. Epub 2010 Jun 22.

PMID:
20573369
9.

A by-product of glutathione production in cancer cells may cause disruption in bone metabolic processes.

Seidlitz EP, Sharma MK, Singh G.

Can J Physiol Pharmacol. 2010 Mar;88(3):197-203. doi: 10.1139/Y09-129. Review.

PMID:
20393585
10.

Luciferase therapeutic microcapsules for gene therapy.

Li AA, Hou DY, Shen F, Seidlitz EP, Potter MA.

Artif Cells Blood Substit Immobil Biotechnol. 2009;37(6):235-44. doi: 10.3109/10731190903356537.

PMID:
19922164
11.

Cancer cells release glutamate via the cystine/glutamate antiporter.

Sharma MK, Seidlitz EP, Singh G.

Biochem Biophys Res Commun. 2010 Jan 1;391(1):91-5. doi: 10.1016/j.bbrc.2009.10.168. Epub 2009 Nov 5.

PMID:
19896463
12.

Cancer cell lines release glutamate into the extracellular environment.

Seidlitz EP, Sharma MK, Saikali Z, Ghert M, Singh G.

Clin Exp Metastasis. 2009;26(7):781-7. doi: 10.1007/s10585-009-9277-4. Epub 2009 Jun 13.

PMID:
19526315
13.

Effect of zoledronic acid on the doxycycline-induced decrease in tumour burden in a bone metastasis model of human breast cancer.

Duivenvoorden WC, Vukmirović-Popović S, Kalina M, Seidlitz E, Singh G.

Br J Cancer. 2007 May 21;96(10):1526-31. Epub 2007 Apr 17.

14.

Cyclooxygenase isoenzymes and patency of ductus arteriosus.

Coceani F, Barogi S, Brizzi F, Ackerley C, Seidlitz E, Kelsey L, Ballou LR, Baragatti B.

Prostaglandins Leukot Essent Fatty Acids. 2005 Feb;72(2):71-7. Review.

PMID:
15626588
15.

Re-expression of TSLC1 in a non-small-cell lung cancer cell line induces apoptosis and inhibits tumor growth.

Mao X, Seidlitz E, Truant R, Hitt M, Ghosh HP.

Oncogene. 2004 Jul 22;23(33):5632-42.

PMID:
15184878
16.
17.

The cytoplasmic domain is critical to the tumor suppressor activity of TSLC1 in non-small cell lung cancer.

Mao X, Seidlitz E, Ghosh K, Murakami Y, Ghosh HP.

Cancer Res. 2003 Nov 15;63(22):7979-85.

18.

Malignant ascites fluid (MAF), including ovarian-cancer-associated MAF, contains angiostatin and other factor(s) which inhibit angiogenesis.

Richardson M, Gunawan J, Hatton MW, Seidlitz E, Hirte HW, Singh G.

Gynecol Oncol. 2002 Sep;86(3):279-87.

PMID:
12217749
19.

The response of the lamb ductus arteriosus to endothelin: developmental changes and influence of light.

Coceani F, Kelsey L, Seidlitz E.

Life Sci. 2002 Jul 26;71(10):1209-17.

PMID:
12095541
20.

Doxycycline decreases tumor burden in a bone metastasis model of human breast cancer.

Duivenvoorden WC, Popović SV, Lhoták S, Seidlitz E, Hirte HW, Tozer RG, Singh G.

Cancer Res. 2002 Mar 15;62(6):1588-91.

21.

Metabolism of rabbit angiostatin glycoforms I and II in rabbits: angiostatin-I leaves the intravascular space faster and appears to have greater anti-angiogenic activity than angiostatin-II.

Hatton MW, Day S, Southward SM, Dereske M, Ross B, Seidlitz E, Singh G, Richardson M.

J Lab Clin Med. 2001 Aug;138(2):83-93.

PMID:
11477374
23.

Deletion of the endothelin-A-receptor suppresses oxygen-induced constriction but not postnatal closure of the ductus arteriosus.

Coceani F, Liu YA, Seidlitz E, Kelsey L, Kuwaki T, Ackerley C, Yanagisawa M.

J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S75-7.

PMID:
11078341
24.

Endothelin A receptor is necessary for O(2) constriction but not closure of ductus arteriosus.

Coceani F, Liu Y, Seidlitz E, Kelsey L, Kuwaki T, Ackerley C, Yanagisawa M.

Am J Physiol. 1999 Oct;277(4):H1521-31. doi: 10.1152/ajpheart.1999.277.4.H1521.

PMID:
10516191
25.

Carbon monoxide formation in the ductus arteriosus in the lamb: implications for the regulation of muscle tone.

Coceani F, Kelsey L, Seidlitz E, Marks GS, McLaughlin BE, Vreman HJ, Stevenson DK, Rabinovitch M, Ackerley C.

Br J Pharmacol. 1997 Feb;120(4):599-608.

26.
27.
28.

Post-activation potentiation and depression in the neocortex of the rat: II. Chronic preparations.

Racine RJ, Teskey GC, Wilson D, Seidlitz E, Milgram NW.

Brain Res. 1994 Feb 21;637(1-2):83-96.

PMID:
8180823
29.

Occurrence of endothelium-derived relaxing factor--nitric oxide in the lamb ductus arteriosus.

Coceani F, Kelsey L, Seidlitz E.

Can J Physiol Pharmacol. 1994 Jan;72(1):82-8.

PMID:
8012902
30.

Evidence for an effector role of endothelin in closure of the ductus arteriosus at birth.

Coceani F, Kelsey L, Seidlitz E.

Can J Physiol Pharmacol. 1992 Jul;70(7):1061-4.

PMID:
1451028
31.

Effects of central and peripheral neuropeptide Y on sodium and water excretion in the rat.

Smyth DD, Wilson JR, Seidlitz E, Thom SL.

Physiol Behav. 1989 Jul;46(1):9-11.

PMID:
2813560
32.

Regulation of renal function by central neuropeptide Y in the anesthetized rat.

Smyth DD, Wilson JR, Seidlitz EP, Thom S.

Proc West Pharmacol Soc. 1989;32:281-4. No abstract available.

PMID:
2780603
33.

[Hemagglutination test for tuberculosis (Middlebrook-Dubos) with papainized blood corpuscles. I. Method].

SCHIFF W, SEIDLITZ E.

Z Immun exp ther. 1954 Jun;111(2):69-89. Undetermined Language. No abstract available.

PMID:
13179737

Supplemental Content

Loading ...
Support Center